Welcome

Thank you very much for your interest in our study. We are attempting to assess the efficacy of Caplyta vs. placebo for the treatment of borderline personality disorder in adults age 18 to 65. The study is conducted under Dr. Jon Grant at the University of Chicago and involves with one initial baseline visit and four follow-up visits via Zoom every two weeks for eight weeks. Participants will be compensated with $40 per visit if they complete the study. The information you provide here will be kept confidential and will not be used for purposes other than seeing if you are eligible to participate in the study.

If you have additional questions, please call 773-702-5523.

Question Title

* 1. Have you been diagnosed with borderline personality disorder?

Question Title

* 2. Are you willing to participate in an 8 week clinical trial where you may receive Caplyta or a placebo?

Question Title

* 3. Do you understand English and can respond to questions, both verbally and written, in the language?

T